Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprorelin 3‑month depot in Chinese children with CPP
CTR20231227Phase 4Completed
- Sponsor
- Takeda
- Start
- Apr 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of leuprolide in central precocious puberty (CPP), sponsored by Takeda. Started Apr 2023; status: completed.
02
Drugs
leuprolide
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on CTR20231227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231227.